false
OasisLMS
Login
Catalog
SHM Converge Scientific Abstract ePoster Gallery
A Rare Case of Myxedema Coma in a Patient With Dis ...
A Rare Case of Myxedema Coma in a Patient With Disseminated Tuberculosis
Back to course
Pdf Summary
This case describes an 80-year-old woman with disseminated tuberculosis who developed myxedema coma during hospitalization for right third DIP osteomyelitis. She initially presented with joint edema and erythema, but family and clinical history also revealed several weeks of waxing and waning confusion, low energy, and poor oral intake. Her TB treatment had included isoniazid, ethambutol, and pyrazinamide, with rifampin stopped two months earlier because of drug-induced liver injury.<br /><br />After admission, she became lethargic, profoundly hypotensive, bradycardic, and hypothermic—classic signs of myxedema coma. Thyroid studies showed severe hypothyroidism (TSH 207 mcU/mL, free T4 0.22 ng/dL), whereas prior labs while she was receiving rifampin had shown only subclinical hypothyroidism. She was diagnosed with myxedema coma and transferred to the ICU. Because of concern for adrenal insufficiency, an ACTH stimulation test was performed and was normal. She was treated with IV levothyroxine and IV liothyronine.<br /><br />The authors suggest that rifampin likely contributed to the patient’s hypothyroidism, which was then worsened by acute infection from Staphylococcus epidermidis osteomyelitis, precipitating myxedema coma. TB infiltration of the thyroid was considered but deemed less likely because her disseminated TB was otherwise improving. This case highlights that anti-tuberculosis medications can be associated with hypothyroidism and that severe infection can trigger decompensation.<br /><br />Myxedema coma is a rare but life-threatening endocrine emergency with mortality rates of 30% to 60%. Early recognition is crucial, especially in older patients with altered mental status, hypotension, or hypothermia. The main treatment is thyroid hormone replacement, usually IV T4, with T3 often added because of its faster biologic effect and impaired peripheral conversion of T4 during severe illness. The patient’s thyroid labs normalized by hospital day 11, and her mental status gradually improved before discharge on hospital day 66.
Asset Subtitle
Nikita G. Deshpande
Meta Tag
Author List
Magdy El-Din MD, Nikita G. Deshpande
Category
Clinical Vignettes
Concept
Myxedema Coma
Concept
Levothyroxine Therapy
Concept
Hypothyroidism
Concept
Altered Mental Status
Concept
IV Thyroid Hormone
Distinguished
Non-Finalist
Presenter Organization
University of Chicago Pritzker School of Medicine
Presenting Author
Nikita G. Deshpande
Track
Adult
Keywords
myxedema coma
hypothyroidism
rifampin
tuberculosis
osteomyelitis
levothyroxine
liothyronine
hypothermia
bradycardia
adrenal insufficiency
Myxedema Coma
Levothyroxine Therapy
Hypothyroidism
Altered Mental Status
IV Thyroid Hormone
×
Please select your language
1
English